Literature DB >> 1590696

Fleroxacin pharmacokinetics in aqueous and vitreous humors determined by using complete concentration-time data from individual rabbits.

M H Miller1, A Madu, G Samathanam, D Rush, C N Madu, K Mathisson, M Mayers.   

Abstract

Although composite data from separate subjects can be used to generate single-subject estimates, intersubject variation precludes rigorous ocular pharmacokinetic analysis. Therefore, a rabbit model in which sequential aqueous and vitreous humor samples were obtained following the administration of the quinolone fleroxacin was developed. Mean data from individual animals were used for pharmacokinetic analysis. Following direct intravitreal or systemic drug administration, sequential paracenteses did not alter pharmacokinetic constants or ocular penetration and were not associated with an increase in ocular protein; contamination of vitreous humor with blood was minimal (less than 0.1%). Following direct injection or intravenous administration, vitreous humor concentration-time data were best described by one- and two-compartment models, respectively. The maximum concentration and the penetration into the aqueous and vitreous humors were 1.54 and 0.5 micrograms/ml and 27 and 10%, respectively. Elimination rates from aqueous and vitreous humors and serum were similar following parenteral drug administration. Drug elimination following direct injection was rapid, and the elimination rate from the vitreous humor was not prolonged by the coadministration of probenecid. Our animal model provides a new approach to the rigorous examination of the ocular pharmacokinetics of quinolone antimicrobial agents in the eye.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1590696      PMCID: PMC189221          DOI: 10.1128/AAC.36.1.32

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  25 in total

1.  [Bacterial endophthalmitis: treatment with a combination of fosfomycin and pefloxacin apropos of 9 cases].

Authors:  A Salvanet-Bouccara; J Feys; B Koffi-Gue; A Fisch; M Cherifi; F Forestier
Journal:  Bull Soc Ophtalmol Fr       Date:  1989-11

2.  High-performance liquid chromatographic determination of 6,8-difluoro-1-(2-fluoroethyl)-1,4- dihydro-7-(4-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid and its metabolites in laboratory animals.

Authors:  H Kusajima; T Ooie; F Kawahara; H Uchida
Journal:  J Chromatogr       Date:  1986-08-22

3.  [Pefloxacine and severe eye infections].

Authors:  I Massin-Cochereau; P Le Hoang; M Weiser; F Rousselie
Journal:  Bull Soc Ophtalmol Fr       Date:  1987 Jun-Jul

4.  In vitro activities of PD 117,596 and reference antibiotics against 448 clinical bacterial strains.

Authors:  R P Smith; A L Baltch; M C Hammer; J V Conroy
Journal:  Antimicrob Agents Chemother       Date:  1988-09       Impact factor: 5.191

5.  Association between early inhibition of DNA synthesis and the MICs and MBCs of carboxyquinolone antimicrobial agents for wild-type and mutant [gyrA nfxB(ompF) acrA] Escherichia coli K-12.

Authors:  R T Chow; T J Dougherty; H S Fraimow; E Y Bellin; M H Miller
Journal:  Antimicrob Agents Chemother       Date:  1988-08       Impact factor: 5.191

6.  In vitro activity of AT-4140 against clinical bacterial isolates.

Authors:  T Kojima; M Inoue; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1989-11       Impact factor: 5.191

7.  Pharmacokinetics of amikacin and chloramphenicol in the aqueous humor of rabbits.

Authors:  M Mayers; D Rush; A Madu; M Motyl; M H Miller
Journal:  Antimicrob Agents Chemother       Date:  1991-09       Impact factor: 5.191

8.  Ocular penetration of 5-fluorocytosine.

Authors:  A Walsh; D A Haft; M H Miller; M R Loran; A H Friedman
Journal:  Invest Ophthalmol Vis Sci       Date:  1978-07       Impact factor: 4.799

9.  Intravitreal antibiotic therapy with vancomycin and aminoglycoside. An experimental study of combination and repetitive injections.

Authors:  B S Oum; D J D'Amico; K W Wong
Journal:  Arch Ophthalmol       Date:  1989-07

10.  Intravitreal vancomycin. Retinal toxicity, clearance, and interaction with gentamicin.

Authors:  S C Pflugfelder; E Hernández; S J Fliesler; J Alvarez; M E Pflugfelder; R K Forster
Journal:  Arch Ophthalmol       Date:  1987-06
View more
  9 in total

1.  Pharmacokinetics of fluconazole in cerebrospinal fluid and serum of rabbits: validation of an animal model used to measure drug concentrations in cerebrospinal fluid.

Authors:  A Madu; C Cioffe; U Mian; M Burroughs; E Tuomanen; M Mayers; E Schwartz; M Miller
Journal:  Antimicrob Agents Chemother       Date:  1994-09       Impact factor: 5.191

2.  Pharmacokinetics of sparfloxacin in the serum and vitreous humor of rabbits: physicochemical properties that regulate penetration of quinolone antimicrobials.

Authors:  W Liu; Q F Liu; R Perkins; G Drusano; A Louie; A Madu; U Mian; M Mayers; M H Miller
Journal:  Antimicrob Agents Chemother       Date:  1998-06       Impact factor: 5.191

3.  Positively charged polymeric nanoparticle reservoirs of terbinafine hydrochloride: preclinical implications for controlled drug delivery in the aqueous humor of rabbits.

Authors:  Saadia Ahmed Tayel; Mohamed Ahmed El-Nabarawi; Mina Ibrahim Tadros; Wessam Hamdy Abd-Elsalam
Journal:  AAPS PharmSciTech       Date:  2013-04-25       Impact factor: 3.246

4.  Pharmacokinetics of [18F]fleroxacin in healthy human subjects studied by using positron emission tomography.

Authors:  A J Fischman; E Livni; J Babich; N M Alpert; Y Y Liu; E Thom; R Cleeland; B L Prosser; J A Correia; H W Strauss
Journal:  Antimicrob Agents Chemother       Date:  1993-10       Impact factor: 5.191

5.  Efficacy and ocular penetration of sparfloxacin in experimental streptococcal endophthalmitis.

Authors:  I Cochereau-Massin; J Bauchet; S Marrakchi-Benjaafar; A Saleh-Mghir; F Faurisson; J M Vallois; E Vallee; J J Pocidalo
Journal:  Antimicrob Agents Chemother       Date:  1993-04       Impact factor: 5.191

6.  Distribution kinetics of enoxacin and its metabolite oxoenoxacin in excretory fluids of healthy volunteers.

Authors:  U Jaehde; F Sörgel; K G Naber; J Zürcher; W Schunack
Journal:  Antimicrob Agents Chemother       Date:  1995-09       Impact factor: 5.191

7.  Tolerability, kinetics, and efficacy of subconjunctival pefloxacin in pigmented rabbits.

Authors:  S Marrakchi-Benjaafar; I Cochereau; F D'Hermies; J J Pocidalo
Journal:  Antimicrob Agents Chemother       Date:  1995-04       Impact factor: 5.191

8.  Pharmacokinetics of ofloxacin in serum and vitreous humor of albino and pigmented rabbits.

Authors:  R J Perkins; W Liu; G Drusano; A Madu; M Mayers; C Madu; M H Miller
Journal:  Antimicrob Agents Chemother       Date:  1995-07       Impact factor: 5.191

9.  Determination of robust ocular pharmacokinetic parameters in serum and vitreous humor of albino rabbits following systemic administration of ciprofloxacin from sparse data sets by using IT2S, a population pharmacokinetic modeling program.

Authors:  G L Drusano; W Liu; R Perkins; A Madu; C Madu; M Mayers; M H Miller
Journal:  Antimicrob Agents Chemother       Date:  1995-08       Impact factor: 5.191

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.